Trials / Completed
CompletedNCT00629733
Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Rovi Pharmaceuticals Laboratories · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Clinical trial to evaluate the tolerability and pharmacokinetics of a new ultra low molecular weight heparin (RO-14) administered subcutaneously increasing single-doses to healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RO-14 |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2007-12-01
- Completion
- 2008-12-01
- First posted
- 2008-03-06
- Last updated
- 2011-06-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00629733. Inclusion in this directory is not an endorsement.